Tower Research Capital LLC TRC Lowers Position in Ambev S.A. (NYSE:ABEV)

Tower Research Capital LLC TRC lessened its stake in Ambev S.A. (NYSE:ABEV) by 82.0% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 15,355 shares of the company’s stock after selling 70,160 shares during the quarter. Tower Research Capital LLC TRC’s holdings in Ambev were worth $43,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Kiltearn Partners LLP boosted its holdings in shares of Ambev by 234.8% in the 4th quarter. Kiltearn Partners LLP now owns 5,868,100 shares of the company’s stock valued at $16,431,000 after buying an additional 4,115,300 shares in the last quarter. Scotia Capital Inc. raised its position in shares of Ambev by 0.3% in the 4th quarter. Scotia Capital Inc. now owns 1,393,397 shares of the company’s stock valued at $3,902,000 after purchasing an additional 4,509 shares during the last quarter. Capstone Investment Advisors LLC purchased a new position in shares of Ambev in the 4th quarter valued at approximately $760,000. Ruffer LLP raised its position in shares of Ambev by 12.4% in the 4th quarter. Ruffer LLP now owns 51,517,699 shares of the company’s stock valued at $144,494,000 after purchasing an additional 5,699,184 shares during the last quarter. Finally, IPG Investment Advisors LLC purchased a new position in shares of Ambev in the 4th quarter valued at approximately $30,000. Hedge funds and other institutional investors own 8.13% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ABEV. StockNews.com began coverage on shares of Ambev in a research report on Friday, January 26th. They issued a “buy” rating for the company. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Ambev in a research report on Friday, March 1st. Finally, Barclays lowered shares of Ambev from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $3.50 to $3.00 in a research report on Monday, March 4th. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, Ambev presently has an average rating of “Moderate Buy” and an average target price of $3.20.

Ambev Price Performance

ABEV traded up $0.07 on Thursday, hitting $2.41. 15,457,929 shares of the company’s stock were exchanged, compared to its average volume of 11,866,915. Ambev S.A. has a fifty-two week low of $2.23 and a fifty-two week high of $3.23. The company has a current ratio of 0.89, a quick ratio of 0.66 and a debt-to-equity ratio of 0.03. The firm has a 50-day moving average price of $2.45 and a 200-day moving average price of $2.62. The stock has a market cap of $37.96 billion, a price-to-earnings ratio of 12.97, a P/E/G ratio of 2.35 and a beta of 1.07.

Ambev (NYSE:ABEV) last announced its quarterly earnings results on Thursday, February 29th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.01. The firm had revenue of $4.04 billion for the quarter. Ambev had a net margin of 18.19% and a return on equity of 17.60%. As a group, equities analysts anticipate that Ambev S.A. will post 0.19 earnings per share for the current year.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.